Skip to content

Clinical trials

Phase 2 Hemoglobinuria, Paroxysmal trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinuria, Paroxysmal Phase: Phase 2 Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20221
20232
20243
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Completed3
Not yet recruiting2
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chengdu Suncadia Medicine Co., Ltd.2
Haisco Pharmaceutical Group Co., Ltd.2
Institute of Hematology & Blood Diseases Hospital, China2
Longbio Pharma2
Kira Pharmacenticals (US), LLC.1
Nanjing Chia-tai Tianqing Pharmaceutical1
S-INFINITY Pharmaceuticals Co., Ltd1
Suzhou Sanegene Bio Inc.1
Wuhan Createrna Science and Technology Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinuria, Paroxysmal13
Anemia2
Anemia, Aplastic2
Anemia, Hemolytic2
Bone Marrow Failure Disorders2
Hematologic Diseases2
Hemoglobinuria2
Proteinuria2
Thrombosis2
Urination Disorders2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.